CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing proprietary targeted medicines primarily for cancer treatment, today announced that the Company will be presenting at the BIO CEO & Investor Conference on Wednesday, February 13th, at the Waldorf-Astoria Hotel in New York City.
